Week 233 Review - Slight recovery but some big drops too.

Although OPTI:Optibiotix climbed 3p, the portfolio climbed less than that due to some big drops elsewhere, most notably CAML:Central Asia Metals. The value improved by £2,909 and the deficit between cost and value narrowed to £30,281, with total value now at £76,939.

Biggest loser was last week's Share of the Week TRMR:Tremor, which gave up 10% of the 16% rise. I knew it was too good to be true that one of the shares in my trading account might be turning around.

IKA:Ilika was Share of the Week the 2 weeks before that, and just as it was about to go into the black, dropped 9% this week and is looking shaky again. Let's hope it was just profit taking.

TLOU:Tlou Energy gave a rather cautious statement about the progress of de-watering the gas beds which triggered a 9% drop on fears that the flows won't be strong enough for a commercial operation. The statement said all indications were still good, but there's more water than was initially anticipated. The key will be maintaining a consistent flow of gas.

I really don't know what could have justified CAML:Central Asia Metals dropping 7% this week. Copper prices are holding, and they were under-priced before the drop. It hammered my performance this week as I hold a lot of these.

Some rare good news for IQE:IQE which climbed 5% this week. Even my best account is 33% down, with my worst a shocking 62% down. We really need the new reactors producing wafers and the 5g infrastructure orders to start roling in.

OPTI:Optibiotix recovered 3p which was 5%, but are still 19% down and losing £14K. I yearn for some news on SweetBiotix which could be the turning point for the share price.

SBTX:SkinBioTherapeutics also recovered from its sympathy dip by 5% in my ISA and 7% in my SIPP. I'm really considering buying some more of these if I dispose of IKA:Ilika or MMX:Minds + Machines, neither of which I regard as long term investments.

Having said that, MMX:Minds + Machines is Share of the Week after a 6% rise has taken it within 3% of being in the black. Do I wait for a dividend announcement or flog them for a small profit so I can get more SBTX?

It looks a disappointingly tiny blip upwards on this chart.

As long as we're still above the trend line I'll be moderately happy.

The ISA and share accounts look like this

			Weekly Change
Cash	£11.99		+£0
Portfolio cost	£57,768.95		+£0
Portfolio sell value (bid price-commission)	£39,668.89	(-31.3%)	+£1,677.46
Potential profits	£0		+£0
Yr 5 Dividends	£0.63		+£0
Yr 5 Profit from sales	£-167.28		+£0
Yr 5 Average monthly cash profit	-£32.14	(-0.7%)	+£1.34
Total Dividends	£1,342.93		+£0
Total Profit from sales	£20,224.13		+£0
Average monthly cash profit	£397.19	(8.3%)	-£1.71
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	12.8%		+0%
Compound performance	57%		+0%

Not much to show other than the OPTI:Optibiotix gains caused most of the uplift. Still no shares in profit, but a few very close.

We didn't cross the orange line, but came very close.

Any upward momentum has vanished of the left hand side. It's 12 months of declining value and every time I think a recovery is about to happen, it plunges downwards again.

The SIPP looks like this after week 217

			Weekly Change
Cash	£74.75		+£0
Portfolio cost	£46,995.31		+£0
Portfolio sell value (bid price - commission)	£35,824.51	(-23.8%)	+£1,283.75
Potential profits	£362.97		-£420.00
Yr 5 Dividends	£0		+£0
Yr 5 Interest	£0.02		+£0
Yr 5 Profit from sales	£0		+£0
Yr 5 Average monthly cash profit	-£13.76	(-0.4%)	+£1.72
Total Dividends	£1,899.24		+£0
Total Interest	£0.18		+£0
Total Profit from sales	£12,549.10		+£0
Average monthly cash profit	£279.10	(7.1%)	-£1.30
(Sold stocks profit + Dividends - Fees / Months)
Performance/Injection	11.2%		-0.1%
Compound performance	47%		+0%

More than half my profits in CAML:Central Asia Metals were wiped out, severely limiting the size of the uplift in value and vexing me considerably.

Below halfway between the injection line and the cost line, which is bad.

Same story of continuous 12 month decline as we see in the ISA.

The trading account looks like this after week 183

		Weekly Change
Cash	£48.24		+£0
Portfolio cost	£2,321.29		+£0
Portfolio sell value (bid price - commission)	£1,311.12	(-43.5%)	-£52.18
Potential profits	£0		+£0
Year 4 Dividends	£13.20		+£0
Year 4 Profit	£0		+£0
Yr 4 Average monthly cash profit	£2.12	(1.1%)	-£0.08
Dividends	£47.92		+£0
Profit from sales	-£64.29		+£0
Average monthly cash profit	-£0.39	(-0.2%)	+£0
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	-0.2%		+0%
Compound performance	-1%		+0%

Most of last weeks gains have gone with big falls for CAML:Central Asia Metals and TRMR:Tremor.

The recovery didn't last.

Some comfort that we're above the trend line.

I've not reported on my magic formula account while I was on holiday, so here's how it performed over the three weeks

			Weekly Change
Cash	£153.61		+£0
Portfolio cost	£29,846.39		+£0
Portfolio sell value (bid price - commission)	£31,169.62	(+4.4%)	+£68.89
Potential profits	£1,898.42		+£366.96
Year 1 Dividends	£0		+£0
Year 1 Profit	£0		+£0
Yr 1 Average monthly cash profit	£0	(0%)	+£0
Dividends	£0		+£0
Profit from sales	£0		+£0
Average monthly cash profit	£0	(0%)	+£0
(Sold stocks profit + Dividends - Fees  / Months)

Potential profits are up by £366 but some losses deepened so overall value is only up by £68. Key thing is it's doing better than my real accounts!

The best performing share is an old holding of mine TW.:Taylor Wimpey, up by 26%, closely followed by BDEV:Barratt Developments up 21% and PSN:Persimmon at 20%. All the house builders seem to be on a Brexit roll.

The worst performers are BUR:Burford Capital down 15% and BMN:Bushveld Minerals down 11%, both of which are in the more risky AIM category and which my due diligence may well filter out of any real purchases.

That's the holiday catch-up finished. Let's hope for a nice week and some form of recovery - and dare I hope for a share to go into profit? IKA:Ilika, MMX:Minds + Machines and JLP:Jubilee Metals are all really close.